Elisabeth Koller

Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A

Richard F. Schlenk, Konstanze Döhner, Silja Mack et al. · Journal of Clinical Oncology · 2010 · 229 citations · Full text

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B

Richard F. Schlenk, Konstanze Döhner, Michael Kneba et al. · Haematologica · 2008 · 208 citations · Full text

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

Richard F Schlenk, Stefan Fröhling, Frank Hartmann et al. · Leukemia · 2004 · 168 citations

Hematological Malignancy, Oncology, Medicine +12

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution

Thomas Nösslinger, Regina Reisner, Elisabeth Koller et al. · Blood · 2001 · 118 citations · Full text

Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with <i>NPM1</i>-mutated AML: results from the AMLSG 09-09 trial

Silke Kapp‐Schwoerer, Daniela Weber, Andrea Corbacioglu et al. · Blood · 2020 · 115 citations · Full text